美国药品NDC(国家药品编码)与药品说明书数据库(U.S. FDA National Drug Code DataBase)
检索条件:" 注册申请号=ANDA204895"
NDC包装代码 产品NDC 产品类型 商品名 通用名 剂型 给药途径 上市日期 结束日期 市场类别 申请号 标签持有者 活性成分 规格 包装描述
65862-744-30 65862-744 HUMAN PRESCRIPTION DRUG Galantamine Galantamine CAPSULE, EXTENDED RELEASE ORAL 20160805 N/A ANDA ANDA204895 Aurobindo Pharma Limited GALANTAMINE HYDROBROMIDE 8 mg/1 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (65862-744-30)
65862-744-90 65862-744 HUMAN PRESCRIPTION DRUG Galantamine Galantamine CAPSULE, EXTENDED RELEASE ORAL 20160805 N/A ANDA ANDA204895 Aurobindo Pharma Limited GALANTAMINE HYDROBROMIDE 8 mg/1 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (65862-744-90)
65862-744-99 65862-744 HUMAN PRESCRIPTION DRUG Galantamine Galantamine CAPSULE, EXTENDED RELEASE ORAL 20160805 N/A ANDA ANDA204895 Aurobindo Pharma Limited GALANTAMINE HYDROBROMIDE 8 mg/1 1000 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (65862-744-99)
65862-745-01 65862-745 HUMAN PRESCRIPTION DRUG Galantamine Galantamine CAPSULE, EXTENDED RELEASE ORAL 20160805 N/A ANDA ANDA204895 Aurobindo Pharma Limited GALANTAMINE HYDROBROMIDE 16 mg/1 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (65862-745-01)
65862-745-05 65862-745 HUMAN PRESCRIPTION DRUG Galantamine Galantamine CAPSULE, EXTENDED RELEASE ORAL 20160805 N/A ANDA ANDA204895 Aurobindo Pharma Limited GALANTAMINE HYDROBROMIDE 16 mg/1 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (65862-745-05)
65862-745-30 65862-745 HUMAN PRESCRIPTION DRUG Galantamine Galantamine CAPSULE, EXTENDED RELEASE ORAL 20160805 N/A ANDA ANDA204895 Aurobindo Pharma Limited GALANTAMINE HYDROBROMIDE 16 mg/1 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (65862-745-30)
65862-745-99 65862-745 HUMAN PRESCRIPTION DRUG Galantamine Galantamine CAPSULE, EXTENDED RELEASE ORAL 20160805 N/A ANDA ANDA204895 Aurobindo Pharma Limited GALANTAMINE HYDROBROMIDE 16 mg/1 1000 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (65862-745-99)
65862-746-01 65862-746 HUMAN PRESCRIPTION DRUG Galantamine Galantamine CAPSULE, EXTENDED RELEASE ORAL 20160805 N/A ANDA ANDA204895 Aurobindo Pharma Limited GALANTAMINE HYDROBROMIDE 24 mg/1 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (65862-746-01)
65862-746-05 65862-746 HUMAN PRESCRIPTION DRUG Galantamine Galantamine CAPSULE, EXTENDED RELEASE ORAL 20160805 N/A ANDA ANDA204895 Aurobindo Pharma Limited GALANTAMINE HYDROBROMIDE 24 mg/1 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (65862-746-05)
65862-746-30 65862-746 HUMAN PRESCRIPTION DRUG Galantamine Galantamine CAPSULE, EXTENDED RELEASE ORAL 20160805 N/A ANDA ANDA204895 Aurobindo Pharma Limited GALANTAMINE HYDROBROMIDE 24 mg/1 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (65862-746-30)
65862-746-90 65862-746 HUMAN PRESCRIPTION DRUG Galantamine Galantamine CAPSULE, EXTENDED RELEASE ORAL 20160805 N/A ANDA ANDA204895 Aurobindo Pharma Limited GALANTAMINE HYDROBROMIDE 24 mg/1 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (65862-746-90)
65862-746-99 65862-746 HUMAN PRESCRIPTION DRUG Galantamine Galantamine CAPSULE, EXTENDED RELEASE ORAL 20160805 N/A ANDA ANDA204895 Aurobindo Pharma Limited GALANTAMINE HYDROBROMIDE 24 mg/1 1000 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (65862-746-99)
65862-745-90 65862-745 HUMAN PRESCRIPTION DRUG Galantamine Galantamine CAPSULE, EXTENDED RELEASE ORAL 20160805 N/A ANDA ANDA204895 Aurobindo Pharma Limited GALANTAMINE HYDROBROMIDE 16 mg/1 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (65862-745-90)
65862-744-05 65862-744 HUMAN PRESCRIPTION DRUG Galantamine Galantamine CAPSULE, EXTENDED RELEASE ORAL 20160805 N/A ANDA ANDA204895 Aurobindo Pharma Limited GALANTAMINE HYDROBROMIDE 8 mg/1 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (65862-744-05)
65862-744-01 65862-744 HUMAN PRESCRIPTION DRUG Galantamine Galantamine CAPSULE, EXTENDED RELEASE ORAL 20160805 N/A ANDA ANDA204895 Aurobindo Pharma Limited GALANTAMINE HYDROBROMIDE 8 mg/1 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (65862-744-01)
商品名称,通用名称,活性成分名称,申请号搜索 高级检索
©2006-2024 Drugfuture->U.S. FDA National Drug Code DataBase